Prevalence and incidence of ischemic heart disease in multiple sclerosis: A population-based validation study

Ruth Ann Marrie1, Bo N Yu1, Stella Leung1

  • 1University of Manitoba, Health Sciences Centre, GF 533, 820 Sherbrook Street, Winnipeg, MB, Canada R3A 1R9.

Abstract

Insights

Multiple sclerosis (MS) patients have a higher incidence of ischemic heart disease (IHD) before age 60. This study validated administrative definitions to assess IHD prevalence and incidence in MS populations.

Area of Science:

  • Cardiovascular Epidemiology
  • Neurology
  • Health Services Research

Background:

  • Limited data exist on ischemic heart disease (IHD) risk in multiple sclerosis (MS).
  • Administrative case definitions for IHD in MS require validation for accurate incidence and prevalence estimation.

Purpose of the Study:

  • To validate administrative case definitions for IHD.
  • To estimate the incidence and prevalence of IHD in a multiple sclerosis population using validated definitions.

Main Methods:

  • Utilized administrative data to identify multiple sclerosis (MSPOP) and matched general population (GPOP) cohorts.
  • Developed and validated IHD case definitions using ICD-9/10 codes and prescription claims against medical records.
  • Applied validated definitions to estimate IHD prevalence and incidence in MS and GPOP cohorts.

Main Results:

  • Moderate agreement (kappa=0.66) was found between administrative definitions and medical records for IHD.
  • In 2005, IHD prevalence was 6.77% in MSPOP vs. 6.11% in GPOP.
  • IHD prevalence and incidence were higher in MSPOP compared to GPOP, particularly in individuals under 60 years old.

Conclusions:

  • Over 5% of the multiple sclerosis population studied has ischemic heart disease.
  • The incidence of IHD is elevated in individuals with MS younger than 60 years.
  • Further research is necessary to understand and address the increased IHD risk in the MS population.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.1K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
799
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
964
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
586
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.4K